At this time, the following NMSOAP studies are ongoing:
Study 1: Blood thinning medications (also known as oral anticoagulants)
This study is collecting information from patients on orally administered “blood thinner” medications for the prevention of atrial fibrillation-related stroke or venous thromboembolic (VTE) disease related pulmonary embolus (blood clots to the lungs). The following are qualifying medications:
- Xarelto® (rivaroxaban)
If you are taking one of these medications, we want to hear from you!